Global Drug-Resistant Tuberculosis Treatment Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Drug-Resistant Tuberculosis Treatment Market Size 2017-2028

2.1.2 Drug-Resistant Tuberculosis Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Drug-Resistant Tuberculosis Treatment Segment by Type

2.2.1 First-Line Anti-TB Drugs

2.2.2 Second-Line Anti-TB Drugs

2.2.3 Others

2.3 Drug-Resistant Tuberculosis Treatment Market Size by Type

2.3.1 Drug-Resistant Tuberculosis Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Drug-Resistant Tuberculosis Treatment Market Size Market Share by Type (2017-2022)

2.4 Drug-Resistant Tuberculosis Treatment Segment by Application

2.4.1 Hospital Pharmacy

2.4.2 Online Pharmacy

2.4.3 Retail Pharmacy

2.4.4 Others

2.5 Drug-Resistant Tuberculosis Treatment Market Size by Application

2.5.1 Drug-Resistant Tuberculosis Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Drug-Resistant Tuberculosis Treatment Market Size Market Share by Application (2017-2022)

3 Drug-Resistant Tuberculosis Treatment Market Size by Player

3.1 Drug-Resistant Tuberculosis Treatment Market Size Market Share by Players

3.1.1 Global Drug-Resistant Tuberculosis Treatment Revenue by Players (2020-2022)

3.1.2 Global Drug-Resistant Tuberculosis Treatment Revenue Market Share by Players (2020-2022)

3.2 Global Drug-Resistant Tuberculosis Treatment Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Drug-Resistant Tuberculosis Treatment by Regions

4.1 Drug-Resistant Tuberculosis Treatment Market Size by Regions (2017-2022)

4.2 Americas Drug-Resistant Tuberculosis Treatment Market Size Growth (2017-2022)

4.3 APAC Drug-Resistant Tuberculosis Treatment Market Size Growth (2017-2022)

4.4 Europe Drug-Resistant Tuberculosis Treatment Market Size Growth (2017-2022)

4.5 Middle East & Africa Drug-Resistant Tuberculosis Treatment Market Size Growth (2017-2022)

5 Americas

5.1 Americas Drug-Resistant Tuberculosis Treatment Market Size by Country (2017-2022)

5.2 Americas Drug-Resistant Tuberculosis Treatment Market Size by Type (2017-2022)

5.3 Americas Drug-Resistant Tuberculosis Treatment Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Drug-Resistant Tuberculosis Treatment Market Size by Region (2017-2022)

6.2 APAC Drug-Resistant Tuberculosis Treatment Market Size by Type (2017-2022)

6.3 APAC Drug-Resistant Tuberculosis Treatment Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Drug-Resistant Tuberculosis Treatment by Country (2017-2022)

7.2 Europe Drug-Resistant Tuberculosis Treatment Market Size by Type (2017-2022)

7.3 Europe Drug-Resistant Tuberculosis Treatment Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Drug-Resistant Tuberculosis Treatment by Region (2017-2022)

8.2 Middle East & Africa Drug-Resistant Tuberculosis Treatment Market Size by Type (2017-2022)

8.3 Middle East & Africa Drug-Resistant Tuberculosis Treatment Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Drug-Resistant Tuberculosis Treatment Market Forecast

10.1 Global Drug-Resistant Tuberculosis Treatment Forecast by Regions (2023-2028)

10.1.1 Global Drug-Resistant Tuberculosis Treatment Forecast by Regions (2023-2028)

10.1.2 Americas Drug-Resistant Tuberculosis Treatment Forecast

10.1.3 APAC Drug-Resistant Tuberculosis Treatment Forecast

10.1.4 Europe Drug-Resistant Tuberculosis Treatment Forecast

10.1.5 Middle East & Africa Drug-Resistant Tuberculosis Treatment Forecast

10.2 Americas Drug-Resistant Tuberculosis Treatment Forecast by Country (2023-2028)

10.2.1 United States Drug-Resistant Tuberculosis Treatment Market Forecast

10.2.2 Canada Drug-Resistant Tuberculosis Treatment Market Forecast

10.2.3 Mexico Drug-Resistant Tuberculosis Treatment Market Forecast

10.2.4 Brazil Drug-Resistant Tuberculosis Treatment Market Forecast

10.3 APAC Drug-Resistant Tuberculosis Treatment Forecast by Region (2023-2028)

10.3.1 China Drug-Resistant Tuberculosis Treatment Market Forecast

10.3.2 Japan Drug-Resistant Tuberculosis Treatment Market Forecast

10.3.3 Korea Drug-Resistant Tuberculosis Treatment Market Forecast

10.3.4 Southeast Asia Drug-Resistant Tuberculosis Treatment Market Forecast

10.3.5 India Drug-Resistant Tuberculosis Treatment Market Forecast

10.3.6 Australia Drug-Resistant Tuberculosis Treatment Market Forecast

10.4 Europe Drug-Resistant Tuberculosis Treatment Forecast by Country (2023-2028)

10.4.1 Germany Drug-Resistant Tuberculosis Treatment Market Forecast

10.4.2 France Drug-Resistant Tuberculosis Treatment Market Forecast

10.4.3 UK Drug-Resistant Tuberculosis Treatment Market Forecast

10.4.4 Italy Drug-Resistant Tuberculosis Treatment Market Forecast

10.4.5 Russia Drug-Resistant Tuberculosis Treatment Market Forecast

10.5 Middle East & Africa Drug-Resistant Tuberculosis Treatment Forecast by Region (2023-2028)

10.5.1 Egypt Drug-Resistant Tuberculosis Treatment Market Forecast

10.5.2 South Africa Drug-Resistant Tuberculosis Treatment Market Forecast

10.5.3 Israel Drug-Resistant Tuberculosis Treatment Market Forecast

10.5.4 Turkey Drug-Resistant Tuberculosis Treatment Market Forecast

10.5.5 GCC Countries Drug-Resistant Tuberculosis Treatment Market Forecast

10.6 Global Drug-Resistant Tuberculosis Treatment Forecast by Type (2023-2028)

10.7 Global Drug-Resistant Tuberculosis Treatment Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Sanofi

11.1.1 Sanofi Company Information

11.1.2 Sanofi Drug-Resistant Tuberculosis Treatment Product Offered

11.1.3 Sanofi Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Sanofi Main Business Overview

11.1.5 Sanofi Latest Developments

11.2 Novartis AG

11.2.1 Novartis AG Company Information

11.2.2 Novartis AG Drug-Resistant Tuberculosis Treatment Product Offered

11.2.3 Novartis AG Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Novartis AG Main Business Overview

11.2.5 Novartis AG Latest Developments

11.3 Endo International plc

11.3.1 Endo International plc Company Information

11.3.2 Endo International plc Drug-Resistant Tuberculosis Treatment Product Offered

11.3.3 Endo International plc Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Endo International plc Main Business Overview

11.3.5 Endo International plc Latest Developments

11.4 CMP Pharma

11.4.1 CMP Pharma Company Information

11.4.2 CMP Pharma Drug-Resistant Tuberculosis Treatment Product Offered

11.4.3 CMP Pharma Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 CMP Pharma Main Business Overview

11.4.5 CMP Pharma Latest Developments

11.5 STI Pharma LLC

11.5.1 STI Pharma LLC Company Information

11.5.2 STI Pharma LLC Drug-Resistant Tuberculosis Treatment Product Offered

11.5.3 STI Pharma LLC Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 STI Pharma LLC Main Business Overview

11.5.5 STI Pharma LLC Latest Developments

11.6 Akorn Incorporated

11.6.1 Akorn Incorporated Company Information

11.6.2 Akorn Incorporated Drug-Resistant Tuberculosis Treatment Product Offered

11.6.3 Akorn Incorporated Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Akorn Incorporated Main Business Overview

11.6.5 Akorn Incorporated Latest Developments

11.7 Lupin

11.7.1 Lupin Company Information

11.7.2 Lupin Drug-Resistant Tuberculosis Treatment Product Offered

11.7.3 Lupin Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Lupin Main Business Overview

11.7.5 Lupin Latest Developments

11.8 Johnson & Johnson Services Inc.

11.8.1 Johnson & Johnson Services Inc. Company Information

11.8.2 Johnson & Johnson Services Inc. Drug-Resistant Tuberculosis Treatment Product Offered

11.8.3 Johnson & Johnson Services Inc. Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Johnson & Johnson Services Inc. Main Business Overview

11.8.5 Johnson & Johnson Services Inc. Latest Developments

11.9 Macleods Pharmaceuticals Ltd

11.9.1 Macleods Pharmaceuticals Ltd Company Information

11.9.2 Macleods Pharmaceuticals Ltd Drug-Resistant Tuberculosis Treatment Product Offered

11.9.3 Macleods Pharmaceuticals Ltd Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Macleods Pharmaceuticals Ltd Main Business Overview

11.9.5 Macleods Pharmaceuticals Ltd Latest Developments

11.10 Pfizer Inc

11.10.1 Pfizer Inc Company Information

11.10.2 Pfizer Inc Drug-Resistant Tuberculosis Treatment Product Offered

11.10.3 Pfizer Inc Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Pfizer Inc Main Business Overview

11.10.5 Pfizer Inc Latest Developments

11.11 Hikma Pharmaceuticals PLC

11.11.1 Hikma Pharmaceuticals PLC Company Information

11.11.2 Hikma Pharmaceuticals PLC Drug-Resistant Tuberculosis Treatment Product Offered

11.11.3 Hikma Pharmaceuticals PLC Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Hikma Pharmaceuticals PLC Main Business Overview

11.11.5 Hikma Pharmaceuticals PLC Latest Developments

11.12 Lannett

11.12.1 Lannett Company Information

11.12.2 Lannett Drug-Resistant Tuberculosis Treatment Product Offered

11.12.3 Lannett Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Lannett Main Business Overview

11.12.5 Lannett Latest Developments

11.13 Mylan N.V.

11.13.1 Mylan N.V. Company Information

11.13.2 Mylan N.V. Drug-Resistant Tuberculosis Treatment Product Offered

11.13.3 Mylan N.V. Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Mylan N.V. Main Business Overview

11.13.5 Mylan N.V. Latest Developments

11.14 Teva Pharmaceutical Industries Ltd

11.14.1 Teva Pharmaceutical Industries Ltd Company Information

11.14.2 Teva Pharmaceutical Industries Ltd Drug-Resistant Tuberculosis Treatment Product Offered

11.14.3 Teva Pharmaceutical Industries Ltd Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Teva Pharmaceutical Industries Ltd Main Business Overview

11.14.5 Teva Pharmaceutical Industries Ltd Latest Developments

11.15 Fresenius Kabi AG

11.15.1 Fresenius Kabi AG Company Information

11.15.2 Fresenius Kabi AG Drug-Resistant Tuberculosis Treatment Product Offered

11.15.3 Fresenius Kabi AG Drug-Resistant Tuberculosis Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Fresenius Kabi AG Main Business Overview

11.15.5 Fresenius Kabi AG Latest Developments

12 Research Findings and Conclusion

Table 1. Drug-Resistant Tuberculosis Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of First-Line Anti-TB Drugs

Table 3. Major Players of Second-Line Anti-TB Drugs

Table 4. Major Players of Others

Table 5. Drug-Resistant Tuberculosis Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 6. Global Drug-Resistant Tuberculosis Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 7. Global Drug-Resistant Tuberculosis Treatment Market Size Market Share by Type (2017-2022)

Table 8. Drug-Resistant Tuberculosis Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global Drug-Resistant Tuberculosis Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 10. Global Drug-Resistant Tuberculosis Treatment Market Size Market Share by Application (2017-2022)

Table 11. Global Drug-Resistant Tuberculosis Treatment Revenue by Players (2020-2022) & ($ Millions)

Table 12. Global Drug-Resistant Tuberculosis Treatment Revenue Market Share by Player (2020-2022)

Table 13. Drug-Resistant Tuberculosis Treatment Key Players Head office and Products Offered

Table 14. Drug-Resistant Tuberculosis Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global Drug-Resistant Tuberculosis Treatment Market Size by Regions 2017-2022 & ($ Millions)

Table 18. Global Drug-Resistant Tuberculosis Treatment Market Size Market Share by Regions (2017-2022)

Table 19. Americas Drug-Resistant Tuberculosis Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 20. Americas Drug-Resistant Tuberculosis Treatment Market Size Market Share by Country (2017-2022)

Table 21. Americas Drug-Resistant Tuberculosis Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 22. Americas Drug-Resistant Tuberculosis Treatment Market Size Market Share by Type (2017-2022)

Table 23. Americas Drug-Resistant Tuberculosis Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 24. Americas Drug-Resistant Tuberculosis Treatment Market Size Market Share by Application (2017-2022)

Table 25. APAC Drug-Resistant Tuberculosis Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 26. APAC Drug-Resistant Tuberculosis Treatment Market Size Market Share by Region (2017-2022)

Table 27. APAC Drug-Resistant Tuberculosis Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 28. APAC Drug-Resistant Tuberculosis Treatment Market Size Market Share by Type (2017-2022)

Table 29. APAC Drug-Resistant Tuberculosis Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 30. APAC Drug-Resistant Tuberculosis Treatment Market Size Market Share by Application (2017-2022)

Table 31. Europe Drug-Resistant Tuberculosis Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 32. Europe Drug-Resistant Tuberculosis Treatment Market Size Market Share by Country (2017-2022)

Table 33. Europe Drug-Resistant Tuberculosis Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 34. Europe Drug-Resistant Tuberculosis Treatment Market Size Market Share by Type (2017-2022)

Table 35. Europe Drug-Resistant Tuberculosis Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 36. Europe Drug-Resistant Tuberculosis Treatment Market Size Market Share by Application (2017-2022)

Table 37. Middle East & Africa Drug-Resistant Tuberculosis Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 38. Middle East & Africa Drug-Resistant Tuberculosis Treatment Market Size Market Share by Region (2017-2022)

Table 39. Middle East & Africa Drug-Resistant Tuberculosis Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Drug-Resistant Tuberculosis Treatment Market Size Market Share by Type (2017-2022)

Table 41. Middle East & Africa Drug-Resistant Tuberculosis Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Drug-Resistant Tuberculosis Treatment Market Size Market Share by Application (2017-2022)

Table 43. Key Market Drivers & Growth Opportunities of Drug-Resistant Tuberculosis Treatment

Table 44. Key Market Challenges & Risks of Drug-Resistant Tuberculosis Treatment

Table 45. Key Industry Trends of Drug-Resistant Tuberculosis Treatment

Table 46. Global Drug-Resistant Tuberculosis Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 47. Global Drug-Resistant Tuberculosis Treatment Market Size Market Share Forecast by Regions (2023-2028)

Table 48. Global Drug-Resistant Tuberculosis Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 49. Global Drug-Resistant Tuberculosis Treatment Market Size Market Share Forecast by Type (2023-2028)

Table 50. Global Drug-Resistant Tuberculosis Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 51. Global Drug-Resistant Tuberculosis Treatment Market Size Market Share Forecast by Application (2023-2028)

Table 52. Sanofi Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors

Table 53. Sanofi Drug-Resistant Tuberculosis Treatment Product Offered

Table 54. Sanofi Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 55. Sanofi Main Business

Table 56. Sanofi Latest Developments

Table 57. Novartis AG Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors

Table 58. Novartis AG Drug-Resistant Tuberculosis Treatment Product Offered

Table 59. Novartis AG Main Business

Table 60. Novartis AG Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 61. Novartis AG Latest Developments

Table 62. Endo International plc Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors

Table 63. Endo International plc Drug-Resistant Tuberculosis Treatment Product Offered

Table 64. Endo International plc Main Business

Table 65. Endo International plc Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. Endo International plc Latest Developments

Table 67. CMP Pharma Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors

Table 68. CMP Pharma Drug-Resistant Tuberculosis Treatment Product Offered

Table 69. CMP Pharma Main Business

Table 70. CMP Pharma Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. CMP Pharma Latest Developments

Table 72. STI Pharma LLC Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors

Table 73. STI Pharma LLC Drug-Resistant Tuberculosis Treatment Product Offered

Table 74. STI Pharma LLC Main Business

Table 75. STI Pharma LLC Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. STI Pharma LLC Latest Developments

Table 77. Akorn Incorporated Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors

Table 78. Akorn Incorporated Drug-Resistant Tuberculosis Treatment Product Offered

Table 79. Akorn Incorporated Main Business

Table 80. Akorn Incorporated Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. Akorn Incorporated Latest Developments

Table 82. Lupin Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors

Table 83. Lupin Drug-Resistant Tuberculosis Treatment Product Offered

Table 84. Lupin Main Business

Table 85. Lupin Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. Lupin Latest Developments

Table 87. Johnson & Johnson Services Inc. Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors

Table 88. Johnson & Johnson Services Inc. Drug-Resistant Tuberculosis Treatment Product Offered

Table 89. Johnson & Johnson Services Inc. Main Business

Table 90. Johnson & Johnson Services Inc. Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. Johnson & Johnson Services Inc. Latest Developments

Table 92. Macleods Pharmaceuticals Ltd Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors

Table 93. Macleods Pharmaceuticals Ltd Drug-Resistant Tuberculosis Treatment Product Offered

Table 94. Macleods Pharmaceuticals Ltd Main Business

Table 95. Macleods Pharmaceuticals Ltd Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 96. Macleods Pharmaceuticals Ltd Latest Developments

Table 97. Pfizer Inc Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors

Table 98. Pfizer Inc Drug-Resistant Tuberculosis Treatment Product Offered

Table 99. Pfizer Inc Main Business

Table 100. Pfizer Inc Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 101. Pfizer Inc Latest Developments

Table 102. Hikma Pharmaceuticals PLC Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors

Table 103. Hikma Pharmaceuticals PLC Drug-Resistant Tuberculosis Treatment Product Offered

Table 104. Hikma Pharmaceuticals PLC Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 105. Hikma Pharmaceuticals PLC Main Business

Table 106. Hikma Pharmaceuticals PLC Latest Developments

Table 107. Lannett Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors

Table 108. Lannett Drug-Resistant Tuberculosis Treatment Product Offered

Table 109. Lannett Main Business

Table 110. Lannett Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 111. Lannett Latest Developments

Table 112. Mylan N.V. Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors

Table 113. Mylan N.V. Drug-Resistant Tuberculosis Treatment Product Offered

Table 114. Mylan N.V. Main Business

Table 115. Mylan N.V. Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 116. Mylan N.V. Latest Developments

Table 117. Teva Pharmaceutical Industries Ltd Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors

Table 118. Teva Pharmaceutical Industries Ltd Drug-Resistant Tuberculosis Treatment Product Offered

Table 119. Teva Pharmaceutical Industries Ltd Main Business

Table 120. Teva Pharmaceutical Industries Ltd Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 121. Teva Pharmaceutical Industries Ltd Latest Developments

Table 122. Fresenius Kabi AG Details, Company Type, Drug-Resistant Tuberculosis Treatment Area Served and Its Competitors

Table 123. Fresenius Kabi AG Drug-Resistant Tuberculosis Treatment Product Offered

Table 124. Fresenius Kabi AG Main Business

Table 125. Fresenius Kabi AG Drug-Resistant Tuberculosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 126. Fresenius Kabi AG Latest Developments

List of Figures

Figure 1. Drug-Resistant Tuberculosis Treatment Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Drug-Resistant Tuberculosis Treatment Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Drug-Resistant Tuberculosis Treatment Market Size Market Share by Type in 2021

Figure 7. Drug-Resistant Tuberculosis Treatment in Hospital Pharmacy

Figure 8. Global Drug-Resistant Tuberculosis Treatment Market: Hospital Pharmacy (2017-2022) & ($ Millions)

Figure 9. Drug-Resistant Tuberculosis Treatment in Online Pharmacy

Figure 10. Global Drug-Resistant Tuberculosis Treatment Market: Online Pharmacy (2017-2022) & ($ Millions)

Figure 11. Drug-Resistant Tuberculosis Treatment in Retail Pharmacy

Figure 12. Global Drug-Resistant Tuberculosis Treatment Market: Retail Pharmacy (2017-2022) & ($ Millions)

Figure 13. Drug-Resistant Tuberculosis Treatment in Others

Figure 14. Global Drug-Resistant Tuberculosis Treatment Market: Others (2017-2022) & ($ Millions)

Figure 15. Global Drug-Resistant Tuberculosis Treatment Market Size Market Share by Application in 2021

Figure 16. Global Drug-Resistant Tuberculosis Treatment Revenue Market Share by Player in 2021

Figure 17. Global Drug-Resistant Tuberculosis Treatment Market Size Market Share by Regions (2017-2022)

Figure 18. Americas Drug-Resistant Tuberculosis Treatment Market Size 2017-2022 ($ Millions)

Figure 19. APAC Drug-Resistant Tuberculosis Treatment Market Size 2017-2022 ($ Millions)

Figure 20. Europe Drug-Resistant Tuberculosis Treatment Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa Drug-Resistant Tuberculosis Treatment Market Size 2017-2022 ($ Millions)

Figure 22. Americas Drug-Resistant Tuberculosis Treatment Value Market Share by Country in 2021

Figure 23. Americas Drug-Resistant Tuberculosis Treatment Consumption Market Share by Type in 2021

Figure 24. Americas Drug-Resistant Tuberculosis Treatment Market Size Market Share by Application in 2021

Figure 25. United States Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC Drug-Resistant Tuberculosis Treatment Market Size Market Share by Region in 2021

Figure 30. APAC Drug-Resistant Tuberculosis Treatment Market Size Market Share by Application in 2021

Figure 31. China Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 35. India Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe Drug-Resistant Tuberculosis Treatment Market Size Market Share by Country in 2021

Figure 38. Europe Drug-Resistant Tuberculosis Treatment Market Size Market Share by Type in 2021

Figure 39. Europe Drug-Resistant Tuberculosis Treatment Market Size Market Share by Application in 2021

Figure 40. Germany Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 41. France Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Drug-Resistant Tuberculosis Treatment Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa Drug-Resistant Tuberculosis Treatment Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa Drug-Resistant Tuberculosis Treatment Market Size Market Share by Application in 2021

Figure 48. Egypt Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country Drug-Resistant Tuberculosis Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)

Figure 54. APAC Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)

Figure 55. Europe Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)

Figure 57. United States Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)

Figure 58. Canada Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)

Figure 59. Mexico Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)

Figure 60. Brazil Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)

Figure 61. China Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)

Figure 62. Japan Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)

Figure 63. Korea Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)

Figure 65. India Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)

Figure 66. Australia Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)

Figure 67. Germany Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)

Figure 68. France Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)

Figure 69. UK Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)

Figure 70. Italy Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)

Figure 71. Russia Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)

Figure 72. Spain Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)

Figure 73. Egypt Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)

Figure 74. South Africa Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)

Figure 75. Israel Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)

Figure 76. Turkey Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries Drug-Resistant Tuberculosis Treatment Market Size 2023-2028 ($ Millions)